Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03707509 |
|---|---|
| Brief Title: | Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma |
| First Submitted : | September 25, 2018 |
| First Submitted that Met QC Criteria : | October 14, 2018 |
| First Posted : | October 16, 2018 |
| Last Update Submitted that Met QC Criteria : | June 30, 2022 |
| Last Update Posted : | July 1, 2022 |